These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 6745203)

  • 1. Serum somatomedin activity and growth hormone secretion by cultured pituitary cells from genetically obese Zucker rats.
    Grzywa M
    Endokrynol Pol; 1984; 35(2):105-11. PubMed ID: 6745203
    [No Abstract]   [Full Text] [Related]  

  • 2. Acute and chronic estrogen effects upon serum somatomedin activity, growth hormone, and prolactin in man.
    Wiedemann E; Schwartz E; Frantz AG
    J Clin Endocrinol Metab; 1976 May; 42(5):942-52. PubMed ID: 178687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum somatomedin activity and growth hormone level in obese men: dependence on degree of obesity and hyperlipidemia.
    Grzywa M
    Exp Clin Endocrinol; 1986 Dec; 88(3):325-33. PubMed ID: 3556417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The growth hormone (GH)-releasing hormone (GHRH)-GH-somatomedin axis: evidence for rapid inhibition of GHRH-elicited GH release by insulin-like growth factors I and II.
    Ceda GP; Davis RG; Rosenfeld RG; Hoffman AR
    Endocrinology; 1987 Apr; 120(4):1658-62. PubMed ID: 3104015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of coadministered growth hormone (GH)-releasing hormone and GH-releasing hexapeptide on maladaptive aspects of obesity in Zucker rats.
    Bercu BB; Yang SW; Masuda R; Hu CS; Walker RF
    Endocrinology; 1992 Dec; 131(6):2800-4. PubMed ID: 1446617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum testosterone and gonadotropins in the genetically obese male Zucker rat.
    Young RA; Frink R; Longcope C
    Endocrinology; 1982 Sep; 111(3):977-81. PubMed ID: 6809449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin-like growth factor I action on rat anterior pituitary cells: suppression of growth hormone secretion and messenger ribonucleic acid levels.
    Yamashita S; Melmed S
    Endocrinology; 1986 Jan; 118(1):176-82. PubMed ID: 3079701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased growth hormone binding to liver membranes of obese Zucker rats.
    Postel-Vinay MC; Durand D; López S; Kayser C; Lavau M
    Horm Metab Res; 1990 Jan; 22(1):7-11. PubMed ID: 2407628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Basal and growth hormone-induced hepatic messenger ribonucleic acid expression of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 is independent of hyperinsulinemia and increased energy status in the genetically obese Zucker rat.
    Melián E; Velasco B; Barrios R; Sanchez-Franco F
    Endocrinology; 1997 Mar; 138(3):1066-71. PubMed ID: 9048610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In situ hybridization study of obesity-associated alteration in growth hormone mRNA levels.
    Ahmad I; Steggles AW; Finkelstein JA
    Int J Obes Relat Metab Disord; 1992 Jun; 16(6):435-41. PubMed ID: 1322869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Somatomedin C: an index of growth hormone activity.
    Kao PC; Abboud CF; Zimmerman D
    Mayo Clin Proc; 1986 Nov; 61(11):908-9. PubMed ID: 3762229
    [No Abstract]   [Full Text] [Related]  

  • 12. Hormonal control of growth in the genetically obese Zucker rat. I. Linear growth, plasma insulin-like growth factor-I (IGF-I) and IGF-binding proteins.
    Nguyen-Yamamoto L; Deal CL; Finkelstein JA; Van Vliet G
    Endocrinology; 1994 Mar; 134(3):1382-8. PubMed ID: 7509740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoreactive corticotropin-releasing hormone levels in brain regions of genetically obese Zucker rats.
    Nakaishi S; Nakai Y; Fukata J; Naito Y; Usui T; Imura H
    Int J Obes; 1990 Nov; 14(11):951-5. PubMed ID: 2276856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Transferrin, somatomedins and growth].
    Donnadieu M; Schimpff RM; Garnier P; Martinez MJ; Chaussain JL; Job JC
    C R Seances Soc Biol Fil; 1980; 174(4):564-73. PubMed ID: 6449240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interrelationship between the effects of insulin-like growth factor I and somatostatin on growth hormone secretion by normal rat pituitary cells: the role of glucocorticoids.
    Lamberts SW; den Holder F; Hofland LJ
    Endocrinology; 1989 Feb; 124(2):905-11. PubMed ID: 2492219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth hormone and prolactin secretion in genetically obese Zucker rats.
    Finkelstein JA; Jervois P; Menadue M; Willoughby JO
    Endocrinology; 1986 Mar; 118(3):1233-6. PubMed ID: 3948775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid changes in somatomedin activity during insulin-induced hypoglycemia: possible release of an inhibitory factor.
    Hill DJ; Potter JM; Cullen DR; Milner RD
    J Clin Endocrinol Metab; 1981 Aug; 53(2):439-42. PubMed ID: 7019232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of growth hormone release: evidence against negative feedback in rat pituitary cells.
    Richman RA; Weiss JP; Hochberg Z; Florini JR
    Endocrinology; 1981 Jun; 108(6):2287-92. PubMed ID: 6112137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Somatomedin activity in sera of genetically small mice.
    Nissley SP; Knazek RA; Wolff GL
    Horm Metab Res; 1980 Apr; 12(4):158-64. PubMed ID: 7390396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Massive growth hormone (GH) discharge in obese subjects after the combined administration of GH-releasing hormone and GHRP-6: evidence for a marked somatotroph secretory capability in obesity.
    Cordido F; Peñalva A; Dieguez C; Casanueva FF
    J Clin Endocrinol Metab; 1993 Apr; 76(4):819-23. PubMed ID: 8473389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.